Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content
Cutting DNA bands from an agarose gel in the laboratory © Laurynas Pliuskys / Graduate Photography Competition

 This four-year graduate programme in chromosome and developmental biology leads to the DPhil degree (PhD). Participating laboratories are international leaders in the fields of chromosome regulation through the mitotic and meiotic cell cycle, the regulation of genome stability and mechanisms of DNA repair, gene/genome regulation in development, including mechanism of transcription, the role of chromatin, nuclear organisation and epigenetic pathways, RNA biogenesis and function (including non-coding RNA), regulating cell fate and pattern formation (including signalling mechanisms and stem cell biology).

Read the full DPhil in Chromosome and Developmental Biology course information on the University of Oxford admissions website

The UK government has confirmed that EU students commencing their studies in 2019/20 will continue to have ‘Home’ fee status and pay fees at the home rate for the duration of their course.  For more information please see http://www.ox.ac.uk/students/oxford-and-the-eu

Supervisors

The following researchers are affiliated with this programme

Alfredo Castello Palomares

Posttranscriptional networks in infection

Ulrike Gruneberg

MRC Senior Research Fellow

Conrad Nieduszynski

Associate Professor of Cell Biology

Paul Riley

BHF Professor of Regenerative Medicine & Chair of Development and Cell Biology

Shankar Srinivas

Professor of Developmental Biology

Clive Wilson

Professor of Cell and Developmental Genetics

Application Deadline

Closed to applications for 2019-20 entry.  The next admissions cycle, for entry to Oxford's graduate courses in 2020-21, will commence on 2 September 2019.

Supported by

Wellcome Trust

Further Information

Statement of Provision